tiprankstipranks
Trending News
More News >
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market

PharmAla Biotech Holdings, Inc. (MDMA) Cash flow

Compare
63 Followers

PharmAla Biotech Holdings, Inc. Cash Flow

TSE:MDMA's free cash flow for Q3 2025 was C$-264.49K. For the 2025 fiscal year, TSE:MDMA's free cash flow was decreased by C$298.61K and operating cash flow was C$-257.04K. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
C$ -321.36KC$ -339.66KC$ -625.37KC$ -173.57K
Investing Cash Flow
C$ -226.42KC$ -506.74KC$ -994.87KC$ 629.22K
Financing Cash Flow
C$ 772.12KC$ 189.29KC$ 0.00C$ 2.02M
End Cash Position
C$ 419.38KC$ 195.04KC$ 852.14KC$ 2.47M
Free Cash Flow
C$ -547.78KC$ -846.39KC$ -1.62MC$ -435.76K
Currency in CAD

PharmAla Biotech Holdings, Inc. Cash Flow